Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 253,946 | 167,594 | 149,640 | 92,130 | 73,302 |
| Receivables | 832,873 | 881,967 | 774,414 | 732,907 | 649,281 |
| Inventories | 102,125 | 95,234 | 78,564 | 77,939 | 75,327 |
| Income taxes - deferred | 218,419 | 149,841 | 120,540 | 107,442 | 83,030 |
| TOTAL | $1,496,819 | $1,374,357 | $1,191,018 | $1,069,497 | $931,080 |
| Non-Current Assets | |||||
| PPE Net | 879,687 | 911,998 | 752,357 | 753,663 | 619,485 |
| Intangibles | 5,882,329 | 6,106,837 | 3,584,392 | 3,344,610 | 2,518,412 |
| Other Non-Current Assets | 144,995 | 172,501 | 133,715 | 138,345 | 134,811 |
| TOTAL | $6,907,011 | $7,191,336 | $4,470,464 | $4,236,618 | $3,272,708 |
| Total Assets | $8,403,830 | $8,565,693 | $5,661,482 | $5,306,115 | $4,203,788 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,142 | 163,581 | 316,874 | 336,839 | 374,801 |
| Accounts payable and accrued liabilities | 1,219,619 | 1,124,716 | 833,996 | 764,453 | 668,987 |
| TOTAL | $1,224,761 | $1,288,297 | $1,150,870 | $1,101,292 | $1,043,788 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,078,089 | 3,377,212 | 1,239,105 | 1,255,386 | 724,021 |
| aiOther Non-Current Liabilities | 444,141 | 549,432 | 252,336 | 186,453 | 147,328 |
| TOTAL | $3,553,935 | $3,953,154 | $1,491,441 | $1,441,839 | $871,349 |
| Total Liabilities | $4,778,696 | $5,241,451 | $2,642,311 | $2,543,131 | $1,915,137 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 190,575 | 194,149 | 193,622 | 198,394 | 202,846 |
| Common Shares | 2,141 | 2,137 | 2,138 | 2,137 | 1,068 |
| Retained earnings | 2,561,679 | 2,057,744 | 1,800,255 | 1,292,510 | 818,734 |
| Other shareholders' equity | -47,751 | 25,536 | -295 | -9,196 | 3,503 |
| TOTAL | $3,625,134 | $3,324,242 | $3,019,171 | $2,762,984 | $2,288,651 |
| Total Liabilities And Equity | $8,403,830 | $8,565,693 | $5,661,482 | $5,306,115 | $4,203,788 |